RecruitingPhase 1NCT06371417
6
studies recruiting now
as of 7 Sept 2026
13
studies registered in total
as of 7 Sept 2026
21
countries with a recruiting site
as of 7 Sept 2026
7 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07072247
RN1201 Injection in the Treatment of Antibody-Mediated Diseases
RecruitingPhase 2NCT06831058
A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
RecruitingNCT07513948
Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura
RecruitingNot applicableNCT06928233
Association of TNFAIP3 With Immune-mediated TTP
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 6 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Immune-mediated thrombotic thrombocytopenic purpura study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Immune-mediated thrombotic thrombocytopenic purpura
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).